<DOC>
	<DOCNO>NCT01829061</DOCNO>
	<brief_summary>The Quo-Test A1C Analyzer Reagent Test System ( Quo-Test A1C System ) intend in-vitro quantitative determination glycated hemoglobin whole blood sample obtain fingerstick venous sample point-of-care testing . The Quo-Test A1C System indicate management treatment diabetes monitor long term glycemic control diabetic . It multiple patient use . Only auto-disabling , single use lance device use system .</brief_summary>
	<brief_title>Reproducibility Method Comparison Studies Quo-Test™ A1C System Quo-Lab A1C Test CLIA Waiver Study Quo-Test™ A1C System</brief_title>
	<detailed_description />
	<criteria>Aged 18 year Able read English Read , understand sign Informed Consent Form Agrees participate withdraw\ Either healthy ( without diabetes ) Type 1 Type 2 diabetes Exlcusion Criteria : • Declines participation withdraws study completion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Type I Diabetes</keyword>
	<keyword>Type II Diabetes</keyword>
	<keyword>HbA1C</keyword>
</DOC>